DEGUM guidelines for amniocentesis and chorionic villus sampling;Empfehlungen der DEGUM zur Durchführung von Amniozentese und Chorionzottenbiopsie

Ultraschall in der Medizin

Volumn 34, Issue 5, 2013, Pages 435-440

  Kahler C ^a   Gembruch, U ^b   Heling, K S ^c   Henrich, W ^d   Schramm, T ^a  

^a Praxis für Pränatalmedizin ^*

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Praxis   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

amniocentesis; chorionic villus sampling; prenatal ultrasound

Indexed keywords

AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; FEMALE; FETUS ECHOGRAPHY; GERMANY; HUMAN; INFORMED CONSENT; METHODOLOGY; NEWBORN; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DIAGNOSIS; PUBLIC HEALTH; RISK FACTOR; STANDARD;

AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; FEMALE; GERMANY; HUMANS; INFANT, NEWBORN; INFORMED CONSENT; NATIONAL HEALTH PROGRAMS; PATIENT EDUCATION AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84886887542     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-0033-1335685     Document Type: Article

References (55)

1. Merz E., Eichhorn K. H., Kaisenberg C. et al. Aktualisierte Qualitätsanforderungen an die weiterführende differenzierte Ultraschalluntersuchung in der pränatalen Diagnostik (= DEGUM-Stufe II) im Zeitraum von 18 + 0 bis 21 + 6 Schwangerschaftswochen. Ultraschall in Med: 2012; 33 593 596
2. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft für Ultraschalldiagnostik (ARGUS), Deutsche Gesellschaft für Ultraschall in der Medizin - Sektion Gynäkologie (DEGUM-Stufe III) Ultraschalluntersuchung in der Frühschwangerschaft. AWMF-Leitlinien-Register Nr. 015/032, 12.10.2010
3. Chaoui R., Heling K. S., Mielke G. et al. Qualitätsanforderungen der DEGUM zur Durchführung der fetalen Echokardiografie. Ultraschall in Med: 2008; 29 197 200 (Pubitemid 351700948)
4. Merz E., Meinel K., Bald R. et al. DEGUM- Stufe- III Empfehlungen zur "weiterführenden" sonographischen Untersuchung (= DEGUM Stufe II) im Zeitraum 11 - 14 Schwangerschaftswochen. Ultraschall in Med: 2004; 25 218 220 (Pubitemid 38756676)
5. Tabor A., Alfirevic Z. Update on Procedure-Related Risks for Prenatal Diagnosis Techniques. Fetal Diagn Ther: 2010; 27 1 7
6. Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet: 1998; 351 242 247
7. Nicolaides K., Brizot M. de L, Patel F. et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet: 1994; 344 435 439 (Pubitemid 24248245)
8. Philip J., Silver R. K., Wilson R. D. et al. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstet Gynecol: 2004; 103 1164 1173 (Pubitemid 40458945)
9. Sundberg K., Bang J., Smidt-Jensen S. et al. Randomised study of the risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet: 1997; 350 697 703 (Pubitemid 27371168)
10. Cederholm M., Haglund B., Axelsson O. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG: 2005; 112 394 402 (Pubitemid 40516550)
11. Firth H. V., Boyd P. A., Chamberlain P. et al. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet: 1991; 337 762 763
12. Mastroiacovo P., Tozzi A. E., Agosti S. et al. Transverse limb reduction defects after chorion villus sampling: a retrospective cohort study. GIDEF - Gruppo Italiano Diagnosi Embrio-Fetali. Prenat Diagn: 1993; 13 1051 1056 (Pubitemid 23350599)
13. WHO/PAHO Consultation of CVS Evaluation of Chorion Villus Sampling Safety. Prenat Diagn: 1999; 19 97 99
14. Royal College of Obstetricians and Gynaecologists Amniocentesis and Chorion Villous Sampling, Green-top Guideline No 8. 2010
15. Gosden C., Tabor A., Leck I. et al. Amniocentesis and chorionic villus sampling. In: Wald N., Leck I. (eds.): Antenatal and Neonatal Screening. London Oxford University Press: 2000; 470 517
16. Fryburg J. S., Dimaio M. S., Yang-Feng T. L. et al. Follow-up of pregnancies complicated by placental mosaicism diagnosed by chorionic villus sampling. Prenatal Diagnosis: 1993; 13 481 494 (Pubitemid 23190352)
17. Tyson R. W. Chromosomal abnormalities in stillbirth and neonatal death. In: Dimmick JE and Kalousek DK (eds.): Developmental pathology of the embryo and fetus. Philadelphia Lippincott: 1992; 103 109
18. Wilkins-Haug L., Quade B., Morton C. C. Confined placental mosaicism as a risk factor among newborns with fetal growth restriction. Prenat Diagn: 2006; 26 28 32
19. Amor D. J., Neo W. T., Waters E. et al. Health and developmental outcome of children following prenatal diagnosis of confined placental mosaicism. Prenat Diagn: 2006; 26 443 448 (Pubitemid 43764443)
20. Miura K., Yoshiura K., Miura S. et al. Clinical outcome of infants with confined placental mosaicism and intrauterine growth restriction of unknown cause. Am J Med Genet A: 2006; 17 1827 1833 (Pubitemid 44330646)
21. Mandelbrot L., Jasseron C., Ekoukou D. et al. Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort. Am J Obstet Gynecol: 2009; 200 160.e1 160.e9
22. Merz E. Invasive pränatale Diagnostik. In: Merz E. (Hrsg.): Sonographische Diagnostik in Gynäkologie und Geburtshilfe. Band 2: Geburtshilfe Thieme: 2002; 532 560
23. Brambati B., Oldrini A., Lanzani A. et al. Transabdominal versus transcervical chorionic villus sampling: a randomized trial. Hum Reprod: 1988; 3 811 813
24. Alfirevic Z., Sundberg K., Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev: 2003; CD003252. 3
25. Smidt-Jensen S. Transabdominal chorionic villus sampling. Method, safety and accuracy. Dan Med Bull: 1998; 45 402 411 (Pubitemid 28419430)
26. Yukobowich E., Anteby E. Y., Cohen S. M. et al. Risk of Fetal Loss in Twin Pregnancies Undergoing Second Trimester Amniocentesis. Obstet Gynecol: 2001; 98 231 234 (Pubitemid 32744754)
27. Agarwal K., Alfirevic Z. Pregnancy Loss after Chorionic Villus Sampling and Genetic Amniocentesis in Twin Pregnancies- a Systematic Review. Ultrasound Obstet Gynecol [published online]: 2012; 10.1002/uog.10152
28. Cahill A. G., Macones G. A., Stamilio D. M. et al. Pregnancy loss rate after mid-trimester amniocentesis in twin pregnancies. Am J Obstet Gynecol: 2009; 200 257.e1 257.e6
29. Vayssière C., Benoist G., Blondel B. et al. Twin pregnancies:guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol: 2011; 156 12 17
30. Seeds J. W. Diagnostic mid trimester amniocentesis: How safe? Am J Obst Gynecol: 2004; 191 608e16
31. Devlieger R., Millar L. K., Bryant-Greenwood G. et al. Fetal membrane healing after spontaneous and iatrogenic membrane rupture: A review of current evidence. Am J Obstet Gynecol: 2006; 195 1512 1520 (Pubitemid 44792593)
32. Borgida A. F., Mills A. A., Feldman D. M. et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol: 2000; 183 937 939
33. Hösli I., Walter-Göbel I., Tercanli S. et al. Spontaneous fetal loss rates in a non-selected population. Am J Med Gene: 2001; 100 106 109
34. Mujezinovic F., Alfirevic Z. Procedure-Related Complications of Amniocentesis and Chorionic Villous Sampling. A Systematic Review. Obstet Gynecol: 2007; 110 687 94 (Pubitemid 47359597)
35. Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. JAMA: 1976; 236 1471 1476
36. An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis. Br J Obstet Gynaecol: 1978; 85 1 41
37. Simpson N. E. et al. Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Can Med Assoc J: 1976; 115 739 748
38. Tabor A., Philip J., Madsen M. et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet: 1986; 1 1287 1293
39. Odibo A. O., Gray D. L., Dicke J. M. et al. Revisiting the Fetal Loss Rate After Second-Trimester Genetic Amniocentesis A Single Center's 16-Year Experience. Obstet Gynecol: 2008; 111 589 595 (Pubitemid 351654062)
40. Eddleman K. A., Malone F. D., Sullivan L. et al. Pregnancy Loss Rates After Midtrimester Amniocentesis. Obstet Gynecol: 2006; 108 1067 1072 (Pubitemid 44665399)
41. Caughey A. B., Hopkins L. M., Norton M. E. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol: 2006; 108 612 616 (Pubitemid 44337103)
42. Kozlowski P., Knippel P., Stressig R. Individual Risk of Fetal Loss Following Routine Second Trimester Amniocentesis: A Controlled Study of 20460 Cases. Ultraschall in Med: 2008; 29 165 172 (Pubitemid 351700943)
43. Tabor A., Vestergaard C. HF, Lidegaard O. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol: 2009; 34 19 24
44. Towner D., Currier R. J., Lorey F. W. et al. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening. Am J Obstet Gynecol: 2007; 196 608.e 1 5
45. Muller F., Thibaud D., Poloce F. et al. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers. Prenat Diagn: 2002; 22 1036 1039 (Pubitemid 35407839)
46. Enzensberger C., Pulvermacher C., Degenhardt J. et al. Fetal Loss Rate and Associated Risk Factors After Amniocentesis, Chorionic Villus Sampling and Fetal Blood Sampling. Ultraschall in Med: 2012; 33 7 E75 E79
47. American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol: 2007; 110 1459 1467
48. Bombard A. T., Powers J. F., Carter S. et al. Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis. Am J Obstet Gynecol: 1995; 172 868 872
49. Marthin T., Liedgren S., Hammar M. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstet Gynecol Scand: 1997; 76 728 732 (Pubitemid 27420404)
50. Hill L. M., Platt L. D., Kellogg B. Rh sensitization after genetic amniocentesis. Obstet Gynecol: 1980; 56 459 461 (Pubitemid 10018305)
51. Johnson J. M., Wilson R. D., Singer J. et al. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial. Prenat Diagn: 1999; 19 732 738 (Pubitemid 29385402)
52. Alfirevic Z. Who should be allowed to perform amniocentesis and chorionic villus sampling? Ultrasound Obstet Gynecol: 2009; 34 12 13
53. Leschot N. J., Verjaal M., Treffers P. E. Risks of midtrimester amniocentesis: assessment in 3,000 pregnancies. Br J Obstet Gynaecol: 1985; 92 804 807 (Pubitemid 16172048)
54. Wijnberger L. DE, van der Schouw Y. T., Christiaens G. CML. Learning in medicine: chorionic villus sampling. Prenat Diagn: 2000; 20 241 246 (Pubitemid 30168835)
55. Nizard J., Duyme M., Ville Y. Teaching ultrasound-guided invasive procedures in fetal medicine: learning curves with and without an electronic guidance system. Ultrasound Obstet Gynecol: 2002; 19 274 277 (Pubitemid 34304575)